Blog Cutting-edge Preclinical QT Assessment Reduces Late-stage Drug Failures Mar 26, 2013 The clinical effects of drugs on cardiac repolarization and rhythm, particularly the induction of potentially fatal arrhythmias have been increasingly documented over the past two decades. The Evolving Regulatory Perspective of Cardiovascular Risk Assessment Mar 04, 2013 The harmonization of regulatory guidance for drug development traces its origins to the European Community (EC) in the mid 1980’s. Mission at Work: Carissa Snedeker Mar 12, 2012 Inspiring stories profiling how Charles River employees and their families are benefiting from our work.
Cutting-edge Preclinical QT Assessment Reduces Late-stage Drug Failures Mar 26, 2013 The clinical effects of drugs on cardiac repolarization and rhythm, particularly the induction of potentially fatal arrhythmias have been increasingly documented over the past two decades.
The Evolving Regulatory Perspective of Cardiovascular Risk Assessment Mar 04, 2013 The harmonization of regulatory guidance for drug development traces its origins to the European Community (EC) in the mid 1980’s.
Mission at Work: Carissa Snedeker Mar 12, 2012 Inspiring stories profiling how Charles River employees and their families are benefiting from our work.
